.png)
Innovative Patient ID & Activation
Life Sciences
Case Background
A global pharmaceutical company had several therapies in the Virology space that were capable of curing or preventing the spread of serious illnesses. This team had made great strides in identifying and activating patients to cure or stop the spread of disease, with over 90% of estimated populations of patients with these diseases already identified and on treatment. To truly eliminate these diseases, the Client team was determined to find and activate the small remaining population but didn’t know how to reach them as so many avenues had already been explored. Our team was engaged to applied our PDI methodology to help generate innovative ideas aimed at identifying and activating patients unaware of their risk.
We began with the FRAME phase, creating a comprehensive 360-degree view of the challenges preventing patients from seeking testing or treatment. By conducting interviews with essential client stakeholders and thoroughly reviewing their relevant strategies and research, we vetted each challenge, identifying which ones, if solved, would generate the greatest return for our client. Three key challenges were selected for Phase 2: HCP Mindsets, Non-Target Patient Demographic Awareness, and Migrant Community Connections. In Phase 2 (CREATE), we searched globally for anyone, anywhere, at any time who had solved parts of these challenges and curated a collection of these precedents. This phase culminated in a CREATIVE RECOMBINATION workshop, where the team used the curated precedents as inspiration to generate new ideas. Several top ideas with significant implications for the team were developed during the workshop. In Phase 3 (PRIME), the team refined each high-potential idea using market-sensing data, internal process logistics, and a best-practices assessment for implementation. Building on this foundation, the team then created actionable pilot and implementation plans, complete with supportive guidance, recommended KPIs, and all necessary materials to seek internal approval and proceed to pilot and launch.
Our Approach
The outputs of our project were found to be transformative and impactful by the client team. We identified three critical challenges and generated innovative solutions through a comprehensive workshop. High-potential ideas were refined with market data and best practices, resulting in actionable pilot and implementation plans. The anticipated outcome of proposed initiatives is increased patient engagement and early intervention, ultimately improving health outcomes and establishing our client as a leader in the Virology segment.
Output
Rejuvenating an Iconic Brand
Government
Case Background
Rockstars in music and elsewhere are not immune to losing social relevance and must reinvent themselves from time to time. Similarly, our Client – an iconic organization behind century-defining scientific and technology breakthroughs – found itself struggling to engage the general public, particularly the next generation of Americans. Despite their historic achievements and contributions to society, they faced the challenge of reconnecting with a younger audience that was largely unaware of their legacy. It became critical for the Client to re-establish wider recognition and garner broader support to continue their mission. This required a strategic reinvention, focusing on contemporary communication methods, leveraging digital platforms, and creating compelling narratives that resonated with younger demographics.
We took a relatively well-framed challenge and deconstructed it to find cases that answer disassociated questions like “Who took somebody doing great things that people don’t understand and make it clear?” and “Who was able to rejuvenate an old asset that had value a long time ago?” The insights from the precedents pointed toward new solutions.
Our Approach
The Client’s team created new public relations initiatives and communication campaigns addressing the audience it was struggling to engage for years. Younger Americans started to not only understand what the Client does but began to fully embrace its role. The impact of the project was substantial enough for the Client team to return with a different challenge that had to be solved with the Precedent Driven Innovation.
Output
Innovative Patient ID & Activation
Life Sciences
Case Background
A global pharmaceutical company had several therapies in the Virology space that were capable of curing or preventing the spread of serious illnesses. This team had made great strides in identifying and activating patients to cure or stop the spread of disease, with over 90% of estimated populations of patients with these diseases already identified and on treatment. To truly eliminate these diseases, the Client team was determined to find and activate the small remaining population but didn’t know how to reach them as so many avenues had already been explored. Our team was engaged to applied our PDI methodology to help generate innovative ideas aimed at identifying and activating patients unaware of their risk.
We began with the FRAME phase, creating a comprehensive 360-degree view of the challenges preventing patients from seeking testing or treatment. By conducting interviews with essential client stakeholders and thoroughly reviewing their relevant strategies and research, we vetted each challenge, identifying which ones, if solved, would generate the greatest return for our client. Three key challenges were selected for Phase 2: HCP Mindsets, Non-Target Patient Demographic Awareness, and Migrant Community Connections. In Phase 2 (CREATE), we searched globally for anyone, anywhere, at any time who had solved parts of these challenges and curated a collection of these precedents. This phase culminated in a CREATIVE RECOMBINATION workshop, where the team used the curated precedents as inspiration to generate new ideas. Several top ideas with significant implications for the team were developed during the workshop. In Phase 3 (PRIME), the team refined each high-potential idea using market-sensing data, internal process logistics, and a best-practices assessment for implementation. Building on this foundation, the team then created actionable pilot and implementation plans, complete with supportive guidance, recommended KPIs, and all necessary materials to seek internal approval and proceed to pilot and launch.
Our Approach
The outputs of our project were found to be transformative and impactful by the client team. We identified three critical challenges and generated innovative solutions through a comprehensive workshop. High-potential ideas were refined with market data and best practices, resulting in actionable pilot and implementation plans. The anticipated outcome of proposed initiatives is increased patient engagement and early intervention, ultimately improving health outcomes and establishing our client as a leader in the Virology segment.